First, after vaccination with Lm-Her2 vaccines, tumors would undergo immunoediting, a process wherein immunological pressure against a TAA will result in selective outgrowth of tumor cells that have mutations in the targeted antigen (Singh and Paterson, 2007a). Here, ERBB2 is linked to neoplasm.